Habib J. Dable - Jun 23, 2022 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
Director
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Stock symbol
BPMC
Transactions as of
Jun 23, 2022
Transactions value $
$0
Form type
4
Date filed
6/27/2022, 06:45 PM
Previous filing
Nov 22, 2021
Next filing
Aug 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Award $0 +3.9K $0.00 3.9K Jun 23, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Award $0 +7.95K $0.00 7.95K Jun 23, 2022 Common Stock 7.95K $56.38 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involved the Reporting Person's receipt of a grant of 3,900 restricted stock units in accordance with the Issuer's non-employee director compensation policy.
F2 This option vests with respect to 1/36th of the shares underlying the option on July 23, 2022 and as to an additional 1/36th of the shares underlying the option each month thereafter.